SNANF
Price
$0.29
Change
-$0.04 (-12.12%)
Updated
Dec 26 closing price
Capitalization
37.98M
Intraday BUY SELL Signals
TDVXF
Price
$10.99
Change
+$0.99 (+9.90%)
Updated
Dec 19 closing price
Capitalization
1.19B
Intraday BUY SELL Signals
Interact to see
Advertisement

SNANF vs TDVXF

Header iconSNANF vs TDVXF Comparison
Open Charts SNANF vs TDVXFBanner chart's image
Sona Nanotech
Price$0.29
Change-$0.04 (-12.12%)
Volume$300
Capitalization37.98M
DYNAVOX GROUP AB
Price$10.99
Change+$0.99 (+9.90%)
Volume$100
Capitalization1.19B
SNANF vs TDVXF Comparison Chart in %
SNANF
Daily Signal:
Gain/Loss:
TDVXF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SNANF vs. TDVXF commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNANF is a Hold and TDVXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (SNANF: $0.29 vs. TDVXF: $10.99)
Brand notoriety: SNANF and TDVXF are both not notable
SNANF represents the Medical Specialties, while TDVXF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SNANF: 3% vs. TDVXF: 39%
Market capitalization -- SNANF: $37.98M vs. TDVXF: $1.19B
SNANF [@Medical Specialties] is valued at $37.98M. TDVXF’s [@Pharmaceuticals: Other] market capitalization is $1.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $204.83B to $0. The average market capitalization across the [@Medical Specialties] industry is $12.47B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNANF’s FA Score shows that 0 FA rating(s) are green whileTDVXF’s FA Score has 2 green FA rating(s).

  • SNANF’s FA Score: 0 green, 5 red.
  • TDVXF’s FA Score: 2 green, 3 red.
According to our system of comparison, TDVXF is a better buy in the long-term than SNANF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNANF’s TA Score shows that 4 TA indicator(s) are bullish while TDVXF’s TA Score has 5 bullish TA indicator(s).

  • SNANF’s TA Score: 4 bullish, 4 bearish.
  • TDVXF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TDVXF is a better buy in the short-term than SNANF.

Price Growth

SNANF (@Medical Specialties) experienced а -15.51% price change this week, while TDVXF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.78%. For the same industry, the average monthly price growth was -3.19%, and the average quarterly price growth was +22.19%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was -3.04%, and the average quarterly price growth was +0.26%.

Industries' Descriptions

@Medical Specialties (+0.78% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TDVXF($1.19B) has a higher market cap than SNANF($38M). TDVXF YTD gains are higher at: 103.519 vs. SNANF (60.493). TDVXF has higher annual earnings (EBITDA): 459M vs. SNANF (-2.36M). TDVXF has more cash in the bank: 172M vs. SNANF (391K). SNANF has less debt than TDVXF: SNANF (436K) vs TDVXF (1.1B). TDVXF has higher revenues than SNANF: TDVXF (2.38B) vs SNANF (0).
SNANFTDVXFSNANF / TDVXF
Capitalization38M1.19B3%
EBITDA-2.36M459M-1%
Gain YTD60.493103.51958%
P/E RatioN/A74.64-
Revenue02.38B-
Total Cash391K172M0%
Total Debt436K1.1B0%
FUNDAMENTALS RATINGS
SNANF: Fundamental Ratings
SNANF
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNANFTDVXF
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
82%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
SNANF
Daily Signal:
Gain/Loss:
TDVXF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGCEX34.190.09
+0.26%
TCW Concentrated Large Cap Growth I Cl
OGLYX89.630.19
+0.21%
Invesco Global Y
RGSCX20.620.02
+0.10%
Virtus KAR Global Small-Cap C
FACVX40.15N/A
N/A
Fidelity Advisor Convertible Secs A
ADOZX23.47-0.05
-0.21%
Alger Dynamic Opportunities Z

SNANF and

Correlation & Price change

A.I.dvisor tells us that SNANF and TDVXF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNANF and TDVXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNANF
1D Price
Change %
SNANF100%
-11.62%
TDVXF - SNANF
24%
Poorly correlated
N/A
SNNUF - SNANF
8%
Poorly correlated
N/A
SSMXY - SNANF
3%
Poorly correlated
-1.01%
SMMNY - SNANF
1%
Poorly correlated
+0.38%
TCHBF - SNANF
0%
Poorly correlated
-0.50%
More

TDVXF and

Correlation & Price change

A.I.dvisor tells us that TDVXF and SNANF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TDVXF and SNANF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TDVXF
1D Price
Change %
TDVXF100%
N/A
SNANF - TDVXF
23%
Poorly correlated
-11.62%
XAIR - TDVXF
23%
Poorly correlated
-7.88%
AHICF - TDVXF
21%
Poorly correlated
N/A
PHCCF - TDVXF
18%
Poorly correlated
N/A
STSS - TDVXF
7%
Poorly correlated
+0.91%
More